Issue 2, 2010

Targeting epigenetic modifiers: Inhibitors of histone methyltransferases

Abstract

The term epigenetics is defined as inheritable changes that influence the outcome of a phenotype without changes in the genome. Epigenetics is based upon DNA methylation and posttranslational histone modifications. While there is much known about reversible acetylation as a posttranslational modification, research on histone methylation is still emerging, especially with regard to drug discovery. As aberrant epigenetic modifications have been linked to many diseases, inhibitors of histone methylation are very much in demand. This article gives an outline on the different histone methyltransferases, their involvement in disease, the available inhibitors and their potential as drugs.

Graphical abstract: Targeting epigenetic modifiers: Inhibitors of histone methyltransferases

Article information

Article type
Review Article
Submitted
29 Apr 2010
Accepted
18 Jun 2010
First published
09 Jul 2010

Med. Chem. Commun., 2010,1, 114-124

Targeting epigenetic modifiers: Inhibitors of histone methyltransferases

E. Bissinger, R. Heinke, W. Sippl and M. Jung, Med. Chem. Commun., 2010, 1, 114 DOI: 10.1039/C0MD00062K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements